Clinical Trial Update: The Reducing Adverse Outcomes in Dialysis by Adjusting the pRescription for Dialysate Potassium Trial [NA]

View source ↗

Summary

This clinical trial entry notes NYU Langone Health's study on adjusting the dialysate potassium prescription to reduce adverse outcomes in patients with end-sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Kidney Disease

Snippet

Sponsor: NYU Langone Health | Conditions: End Stage Kidney Disease | NA | Status: NOT_YET_RECRUITING